SBFM Q2 2019 Earnings — Sunshine Biopharma, Inc. Revenue & Financial Results | Market Cap Arena

SBFMSunshine Biopharma, Inc.

$6M

Q2 2019 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$3,033-97.2% YoY

Gross Profit

$1,57351.9% margin

Operating Income

-$66,197-2182.6% margin

Net Income

-$710,890-23438.5% margin

EPS (Diluted)

$-7.15

QoQ Revenue Growth

+1372.3%

Cash Flow

Operating Cash Flow

-$47,464

Free Cash Flow

-$47,949

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$109,389

Total Liabilities

$925,691

Stockholders' Equity

-$816,302

Cash & Equivalents

$37,277

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$3,033	$107,250	-97.2%
Gross Profit	$1,573	$15,619	-89.9%
Operating Income	-$66,197	-$580,511	+88.6%
Net Income	-$710,890	-$644,308	-10.3%